CD62L was expressed by about 90% of PB Tregs in both patient groups and decreased significantly in the SM samples to 2% in RA patients and 3.1% in OA patients (P = 0.0293 and P = 0.0001, respectively). Here, SELL is linked to rheumatoid arthritis.